Israel Englander Medicinova Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Medicinova Inc stock. As of the latest transaction made, Millennium Management LLC holds 24,886 shares of MNOV stock, worth $38,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,886

Previous 30,048 17.18%

Holding current value

$38,822

Previous $43,000 18.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.57 $6,607 - $8,104	-5,162 Reduced 17.18%	24,886 $35,000
Q1 2024 May 15, 2024	SELL	$1.28 - $1.65 $8,117 - $10,464	-6,342 Reduced 17.43%	30,048 $43,000
Q4 2023 Feb 14, 2024	SELL	$1.38 - $2.06 $254,356 - $379,690	-184,316 Reduced 83.51%	36,390 $54,000
Q2 2023 Aug 14, 2023	SELL	$2.09 - $2.43 $65,281 - $75,901	-31,235 Reduced 12.4%	220,706 $507,000
Q1 2023 May 15, 2023	BUY	$1.95 - $2.54 $614 - $800	315 Added 0.13%	251,941 $544,000
Q4 2022 Feb 14, 2023	SELL	$1.97 - $2.66 $199,620 - $269,537	-101,330 Reduced 28.71%	251,626 $516,000
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.6 $6,230 - $7,714	-2,967 Reduced 0.83%	352,956 $766,000
Q2 2022 Aug 15, 2022	SELL	$2.31 - $3.14 $50,517 - $68,668	-21,869 Reduced 5.79%	355,923 $900,000
Q1 2022 May 16, 2022	SELL	$2.19 - $2.81 $29,405 - $37,729	-13,427 Reduced 3.43%	377,792 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.42 $29,232 - $49,504	11,200 Added 2.95%	391,219 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $1.02 Million - $1.27 Million	-299,784 Reduced 44.1%	380,019 $1.44 Million
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $2.56 Million - $3.49 Million	679,803 New	679,803 $2.89 Million
Q1 2021 May 17, 2021	SELL	$4.81 - $8.74 $189,124 - $343,648	-39,319 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.03 - $6.31 $197,774 - $248,102	39,319 New	39,319 $207,000
Q3 2020 Nov 16, 2020	SELL	$4.67 - $11.0 $90,906 - $214,126	-19,466 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.06 - $7.06 $49,067 - $113,207	-16,035 Reduced 45.17%	19,466 $106,000
Q1 2020 May 14, 2020	SELL	$2.9 - $6.97 $178,010 - $427,839	-61,383 Reduced 63.36%	35,501 $132,000
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $627,808 - $848,703	96,884 New	96,884 $653,000
Q3 2019 Nov 14, 2019	SELL	$7.7 - $10.42 $869,961 - $1.18 Million	-112,982 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $936,620 - $1.49 Million	112,982 New	112,982 $1.09 Million

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.69M

Call Options Held

7.2K

Put Options Held

3.8K

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $76.5M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account